SEASON34

Nearly 40 percent of a woman's lifetime is spent navigating hormone shifts, yet most products still treat menopause as a single symptom—or ignore it entirely. Seeing this gap, serial wellness entrepreneur Irene Rojas Stanbury and her mother, Dr. Maria Guadalupe Stanbury, a physician-researcher with 40 years in women's metabolic health, set out to rewrite the playbook. In early 2024 they began a year-long R&D sprint, pairing Irene's $23 million direct-to-consumer track record with Dr. Maria's clinical insight. Their goal was bold but clear: build the first brand engineered to address all 34 documented menopause symptoms with drug- and hormone-free precision. The result is SEASON34, debuting at this show as a turnkey opportunity for retailers and healthcare partners eager to serve an underserved $6 billion U.S. category poised for double-digit growth. Launching with nine patent-pending formulas—including a menopause-specific synbiotic, hormonal balance blend, and targeted solutions for sleep, cognition, metabolism, and more—SEASON34 offers an integrative system that women can personalize through quizzes, symptom tracking, and 1-to-1 coaching. Every ingredient is clinically dosed, third-party tested, and packed in two-year-shelf-life, refill-ready packaging. But SEASON34 is more than capsules in a bottle. It is a stigma-free ecosystem built on three pillars: Science without compromise — gold-standard actives, transparent labels, and ongoing clinical trials. Compassion in every touchpoint — education, coaching, and community that turn confusion into confidence. Seamless integration — subscription models, an app, and retailer-ready merchandising that fit effortlessly into modern lifestyles. By treating menopause as a powerful season of renewal rather than decline, SEASON34 invites partners to elevate an entire generation's well-being—and capture meaningful, repeatable revenue—in one decisive move. Join us as we turn a long-overlooked life stage into a vibrant, profitable, and dignified new market.